Febrile seizure risk following monovalent COVID-19 mRNA vaccination in US children aged 2-5 years. Anderson SA, Smith ER, Wan Z, Amend KL, et al. Vaccine 2026;75:128225.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anderson SA, Smith ER, Wan Z, Amend KL, et al. Febrile seizure risk following monovalent COVID-19 mRNA vaccination in US children aged 2-5 years. Vaccine 2026;75:128225.
PMID: 41643233